274 related articles for article (PubMed ID: 26172478)
1. Biomarkers for Diagnosis and Prognosis of Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation.
Akil A; Zhang Q; Mumaw CL; Raiker N; Yu J; Velez de Mendizabal N; Haneline LS; Robertson KA; Skiles J; Diaz-Ricart M; Carreras E; Renbarger J; Hanash S; Bies RR; Paczesny S
Biol Blood Marrow Transplant; 2015 Oct; 21(10):1739-45. PubMed ID: 26172478
[TBL] [Abstract][Full Text] [Related]
2. Low Plasma Levels of Hyaluronic Acid Might Rule Out Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell Transplantation.
De Ramón Ortiz C; Justo Sanz R; Beauverd Y; Humala K; López de la Guia A; De Paz R; Gasior M; Gómez Prieto P; Fabra Urdiola M; Canales Albendea M; Butta N; Jiménez Yuste V
Dis Markers; 2023; 2023():7589017. PubMed ID: 37101837
[TBL] [Abstract][Full Text] [Related]
3. Prospective assessment of risk biomarkers of sinusoidal obstruction syndrome after hematopoietic cell transplantation.
Han Y; Bidgoli A; DePriest BP; Méndez A; Bijangi-Vishehsaraei K; Perez-Albuerne ED; Krance RA; Renbarger J; Skiles JL; Choi SW; Liu H; Paczesny S
JCI Insight; 2023 May; 8(10):. PubMed ID: 37071469
[TBL] [Abstract][Full Text] [Related]
4. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.
Dignan FL; Wynn RF; Hadzic N; Karani J; Quaglia A; Pagliuca A; Veys P; Potter MN; ;
Br J Haematol; 2013 Nov; 163(4):444-57. PubMed ID: 24102514
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Biomarkers for Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Myeloablative Allogeneic Hematopoietic Cell Transplantation: Results from the Blood and Marrow Transplant Clinical Trials Network 1202 Study.
Putta S; Young BA; Levine JE; Reshef R; Nakamura R; Strouse C; Perales MA; Howard A; Pine P; Shi J; Zhang P; Ho VT; Saber W
Transplant Cell Ther; 2023 Mar; 29(3):166.e1-166.e10. PubMed ID: 36574581
[TBL] [Abstract][Full Text] [Related]
6. Early Clinical Predictors of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Myeloablative Stem Cell Transplantation.
Roeker LE; Kim HT; Glotzbecker B; Nageshwar P; Nikiforow S; Koreth J; Armand P; Cutler C; Alyea EP; Antin JH; Richardson PG; Soiffer RJ; Ho VT
Biol Blood Marrow Transplant; 2019 Jan; 25(1):137-144. PubMed ID: 30081073
[TBL] [Abstract][Full Text] [Related]
7. Liver Stiffness Measurement Allows Early Diagnosis of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Adult Patients Who Undergo Hematopoietic Stem Cell Transplantation: Results from a Monocentric Prospective Study.
Colecchia A; Ravaioli F; Sessa M; Alemanni VL; Dajti E; Marasco G; Vestito A; Zagari RM; Barbato F; Arpinati M; Cavo M; Festi D; Bonifazi F
Biol Blood Marrow Transplant; 2019 May; 25(5):995-1003. PubMed ID: 30660772
[TBL] [Abstract][Full Text] [Related]
8. Earlier defibrotide initiation post-diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome improves Day +100 survival following haematopoietic stem cell transplantation.
Richardson PG; Smith AR; Triplett BM; Kernan NA; Grupp SA; Antin JH; Lehmann L; Miloslavsky M; Hume R; Hannah AL; Nejadnik B; Soiffer RJ
Br J Haematol; 2017 Jul; 178(1):112-118. PubMed ID: 28444784
[TBL] [Abstract][Full Text] [Related]
9. Burden of illness associated with sinusoidal obstruction syndrome/veno-occlusive disease in patients with hematopoietic stem cell transplantation.
Cao Z; Villa KF; Lipkin CB; Robinson SB; Nejadnik B; Dvorak CC
J Med Econ; 2017 Aug; 20(8):871-883. PubMed ID: 28562132
[TBL] [Abstract][Full Text] [Related]
10. Validation of treatment outcomes according to revised severity criteria from European Society for Blood and Marrow Transplantation (EBMT) for sinusoidal obstruction syndrome/veno-occlusive disease (SOS/VOD).
Yoon JH; Yoo KH; Sung KW; Jung CW; Kim JS; Hahn SM; Kang HJ; Lee JH; Im HJ; Ahn JS; Kook H; Cho B; Lee JW
Bone Marrow Transplant; 2019 Aug; 54(8):1361-1368. PubMed ID: 30809031
[TBL] [Abstract][Full Text] [Related]
11. Analysis of laboratory parameters before the occurrence of hepatic sinusoidal obstruction syndrome in children, adolescents, and young adults after hematopoietic stem cell transplantation.
Johann L; Gruhn B
J Cancer Res Clin Oncol; 2024 Jan; 150(1):9. PubMed ID: 38206490
[TBL] [Abstract][Full Text] [Related]
12. Defibrotide for Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome: Interim Results from a Treatment IND Study.
Richardson PG; Smith AR; Triplett BM; Kernan NA; Grupp SA; Antin JH; Lehmann L; Shore T; Iacobelli M; Miloslavsky M; Hume R; Hannah AL; Nejadnik B; Soiffer RJ;
Biol Blood Marrow Transplant; 2017 Jun; 23(6):997-1004. PubMed ID: 28285079
[TBL] [Abstract][Full Text] [Related]
13. Risk Factors for Development of and Progression of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome.
Corbacioglu S; Jabbour EJ; Mohty M
Biol Blood Marrow Transplant; 2019 Jul; 25(7):1271-1280. PubMed ID: 30797942
[TBL] [Abstract][Full Text] [Related]
14. Grayscale and Spectral Doppler Ultrasound in the Diagnosis of Hepatic Veno-occlusive Disease/Sinusoidal Obstruction Syndrome After Hematopoietic Stem Cell Transplantation in Children.
Kaya N
J Pediatr Hematol Oncol; 2021 Nov; 43(8):e1105-e1110. PubMed ID: 34673713
[TBL] [Abstract][Full Text] [Related]
15. Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation.
Mohty M; Malard F; Abecassis M; Aerts E; Alaskar AS; Aljurf M; Arat M; Bader P; Baron F; Bazarbachi A; Blaise D; Ciceri F; Corbacioglu S; Dalle JH; Dignan F; Fukuda T; Huynh A; Masszi T; Michallet M; Nagler A; NiChonghaile M; Okamoto S; Pagliuca A; Peters C; Petersen FB; Richardson PG; Ruutu T; Savani BN; Wallhult E; Yakoub-Agha I; Duarte RF; Carreras E
Bone Marrow Transplant; 2016 Jul; 51(7):906-12. PubMed ID: 27183098
[TBL] [Abstract][Full Text] [Related]
16. Prediction of veno-occlusive disease using biomarkers of endothelial injury.
Cutler C; Kim HT; Ayanian S; Bradwin G; Revta C; Aldridge J; Ho V; Alyea E; Koreth J; Armand P; Soiffer R; Ritz J; Richardson PG; Antin JH
Biol Blood Marrow Transplant; 2010 Aug; 16(8):1180-5. PubMed ID: 20184961
[TBL] [Abstract][Full Text] [Related]
17. Hepatic sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation in adult patients with idiopathic aplastic anemia.
Kim H; Lee KH; Sohn SK; Jung CW; Joo YD; Kim SH; Kim BS; Choi JH; Kwak JY; Kim MK; Bae SH; Shin HJ; Won JH; Oh S; Lee WS; Park JH; Yoon SS
Leuk Res; 2013 Oct; 37(10):1241-7. PubMed ID: 23871157
[TBL] [Abstract][Full Text] [Related]
18. Hepatic Veno-Occlusive Disease after Hematopoietic Stem Cell Transplantation: Risk Factors and Stratification, Prophylaxis, and Treatment.
Dalle JH; Giralt SA
Biol Blood Marrow Transplant; 2016 Mar; 22(3):400-9. PubMed ID: 26431626
[TBL] [Abstract][Full Text] [Related]
19. Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease: Final Results From the International Compassionate-Use Program.
Corbacioglu S; Carreras E; Mohty M; Pagliuca A; Boelens JJ; Damaj G; Iacobelli M; Niederwieser D; Olavarría E; Suarez F; Ruutu T; Verdonck L; Hume R; Nejadnik B; Lai C; Finetto G; Richardson P
Biol Blood Marrow Transplant; 2016 Oct; 22(10):1874-1882. PubMed ID: 27397724
[TBL] [Abstract][Full Text] [Related]
20. New insights into sinusoidal obstruction syndrome.
Piccin A; Sartori MT; Bisogno G; Van Schilfgaarde M; Saggiorato G; Pierro AMD; Corvetta D; Marcheselli L; Mega A; Gastl G; Cesaro S
Intern Med J; 2017 Oct; 47(10):1173-1183. PubMed ID: 28707749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
